
结论很明确:这个市场不值得进入,已经处在高竞争、明显偏价格战的状态。 新品牌只有7个,但近一年新品牌里真正盈利的只占16.22%,新品整体成功率也只有16.98%,失败率高达80%;而且市场里已经有WALK·HERO COMFORT AND SUPPORT、Dr. Scholl's 这类老牌强者长期吃量,说明新进入者很难靠普通打法站稳。\n\n证据很直接:多数新品利润并不健康,且近几个月进入越来越密集,但结果没有改善。 新品利润区间显示,15.41%和16.7%只是少数成功样本,真正赚钱的新品并不多;新品牌样本里,XGXC 12个产品只有2个盈利、10个亏损,总预算约53503.72元,盈利率16.67%,说明“有钱投”也不代表能赢。反过来,Flyantilope 4个新品全亏,Ucanfeel 4个新品全亏,属于失败样本;更危险的是,像 XGXC 的 B0GJSHF5YW(约1076.54 USD预算、15.41%利润、月销50、月收入67600)和 B0GWZQ5LL8(约8445.84 USD预算、16.7%利润、月销100、月收入140700)这类成功样本,利润并不高,靠的是强运营和持续投放,不是低成本轻松复制。与此同时,B0DY5CTQF5、B0GV3GT3CG、B0GF8FL5S8、B0GF7KY18X、B0GF8VRP97 等新品评论已到38~271条,明显有激进投放甚至“predatory competitors”的味道,说明市场里已经有人在用高压打法抢量。\n\n对两类卖家的判断都一样:大品牌可以勉强硬打,小商家不适合进。 大品牌如果真要进,至少要对标 WALK·HERO COMFORT AND SUPPORT 的老品矩阵和 Dr. Scholl's 的高价高量打法,前者单品月收入可到11196000、9320000、7468000,利润率约27.72%~29.98%,这是典型品牌势能,不是普通新玩家能复制;小商家可参考的真正成功样本只有 Psveb 的 B0G1RP8VKW,预算约2385 USD、月销100、月收入238500、约4.5星1120条评价,但这已经是高评价、高运营强度路线。结合你的50万CNY预算,虽然能覆盖单个ASIN的起步,但这只够前期供货和投放,不足以形成长期优势;所以结论是不进场。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
结论很明确:这个市场不值得进入。 用户预算50万CNY看起来足以覆盖单个新品的起步成本,但市场已经进入明显的价格战区,新品盈利率只有16.98%,整体可盈利产品也只有52.78%,而且大量新品在近几个月集中出现却大多不赚钱,说明竞争在加剧而不是变好。
预算上是够起步的,但不够构成优势。 这个市场的新上市产品推荐预算中位数约为8445.84 USD,最低约1076.54 USD,最高约12310.12 USD;用户50万CNY大概能覆盖单个ASIN的前期投入,但这只够前几个月的供货、物流和投放,不包含研发、品牌和认证等长期成本。对比样本里真正赚钱的产品,XGXC有2个盈利ASIN:B0GWZQ5LL8(约8445.84 USD预算、16.7%利润率、月销100、月收入140700)和B0GJSHF5YW(约1076.54 USD预算、15.41%利润率、月销50、月收入67600);但同品牌也有10个不赚钱新品,Flyantilope、Ucanfeel两个新品牌则是0盈利,属于失败样本。更关键的是,近几个月新品投放越来越密集,2026年1月起每月都有大量新品进入,但多数是非盈利或未证明盈利,已经出现明显的拥挤和内卷。
给大品牌的参考只有老牌强者WALK·HERO COMFORT AND SUPPORT;给小品牌的唯一可学样本是Psveb的B0G1RP8VKW。 WALK·HERO COMFORT AND SUPPORT 作为老品牌,靠B075YH3D7N、B0C3C3WZMV、B0CR6GPNKG这类老品持续吃量,单品月收入分别约11196000、9320000、1684800,利润率在27.72%~29.98%,这是典型的品牌力和历史积累,不适合作为小商家路径;而小商家里真正接近可复制的成功案例是Psveb的B0G1RP8VKW,约2385 USD预算、4.5星、1120条评价、月销100、月收入238500,但这已经逼近“需要强运营+高评价支撑”的打法,不是低成本轻松进入。相反,像Flyantilope的B0DY5CTQF5、B0DY5D29H1、Ucanfeel的B0GF8FL5S8、B0GF7KY18X、B0GF8VRP97、XGXC的B0GV3GT3CG、B0GV3RXWQ2都表现为失败或低利润,且部分新品评论已到90~284条,属于高度激进营销甚至偏“predatory competitors”的信号。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不值得进入,已经是高风险的价格战市场。 新品牌里,Ucanfeel、Flyantilope、XGXC 这类新入场者几乎都是失败为主;新品牌新上架盈利率只有16.22%,但非盈利率高达70.27%,而且像 XGXC 这种新品牌虽然有 12 个产品、总预算约 53,503.72 元,却只有 2 个盈利、10 个亏损,说明不是“低成本就能做”,而是很容易陷入烧钱换销量。
这个市场不适合进入,结论很明确:新品失败率高、低价内卷严重,而且新品牌里真正赚钱的案例几乎都不是普通小卖家。 以新品为准,盈利产品只占18.75%,未盈利占81.25%;再看已知利润区间,20%以下的新品占11.32%,10%以下的新品占9.44%,说明低利润和亏损样本不少,价格战已经很重。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0BM657VJP | VALSOLE | 2022-12-04 | Yes | $30.79 | 4000pcs | $123160.0 | 37.39% | $46049.53 |
![]() | B075YH3D7N | WALK·HERO COMFORT AND SUPPORT | 2017-09-27 | Yes | $18.66 | 6000pcs | $111960.0 | 27.91% | $31248.04 |
![]() | B0C3C3WZMV | WALK·HERO COMFORT AND SUPPORT | 2023-04-24 | Yes | $18.64 | 5000pcs | $93200.0 | 29.98% | $27941.36 |
![]() | B0FLXR8J8R | Dr. Scholl's | 2025-08-11 | Yes | $36.03 | 2000pcs | $72060.0 | 37.76% | $27209.86 |
![]() | B075YGGG1X | WALK·HERO COMFORT AND SUPPORT | 2017-09-27 | Yes | $18.65 | 4000pcs | $74600.0 | 30.03% | $22402.38 |
![]() | B09L38FF2B | CRUVHEAL | 2021-11-05 | Yes | $29.99 | 2000pcs | $59980.0 | 35.85% | $21502.83 |
![]() | B075YFMJVQ | WALK·HERO COMFORT AND SUPPORT | 2017-09-27 | Yes | $18.67 | 4000pcs | $74680.0 | 27.72% | $20701.3 |
![]() | B0FBX6SK94 | Dr. Scholl's | 2025-06-04 | Yes | $29.94 | 2000pcs | $59880.0 | 32.32% | $19353.22 |
![]() | B0D65VKYY6 | WALK·HERO COMFORT AND SUPPORT | 2024-06-05 | Yes | $18.5 | 3000pcs | $55500.0 | 29.57% | $16411.35 |
![]() | B0FLY357SS | Dr. Scholl's | 2025-08-11 | Yes | $37.64 | 1000pcs | $37640.0 | 38.27% | $14404.83 |
![]() | B0FLY3KSFV | Dr. Scholl's | 2025-08-11 | Yes | $36.92 | 1000pcs | $36920.0 | 38.21% | $14107.14 |
![]() | B0FLY3V53V | Dr. Scholl's | 2025-08-11 | Yes | $36.03 | 1000pcs | $36030.0 | 38.08% | $13720.23 |
![]() | B0DK786TKV | WALK·HERO COMFORT AND SUPPORT | 2024-10-17 | Yes | $17.02 | 3000pcs | $51060.0 | 25.28% | $12907.97 |
B0FLY3ZS3X | Dr. Scholl's | 2025-08-11 | Yes | $36.68 | 900pcs | $33012.0 | 36.39% | $12013.07 | |
![]() | B0D48FFHJS | WALK·HERO COMFORT AND SUPPORT | 2024-05-16 | Yes | $18.58 | 2000pcs | $37160.0 | 29.92% | $11118.28 |
![]() | B09L39Z6M5 | CRUVHEAL | 2022-01-22 | Yes | $29.99 | 1000pcs | $29990.0 | 35.73% | $10715.43 |
![]() | B0BFJG28VG | CRUVHEAL | 2022-09-16 | Yes | $29.99 | 1000pcs | $29990.0 | 34.99% | $10493.51 |
B0FBX87NHP | Dr. Scholl's | 2025-06-04 | Yes | $30.97 | 1000pcs | $30970.0 | 33.13% | $10260.37 | |
![]() | B0FLY4HCJ9 | Dr. Scholl's | 2025-08-11 | Yes | $36.26 | 700pcs | $25382.0 | 37.95% | $9632.47 |
B0DK78PNDC | WALK·HERO COMFORT AND SUPPORT | 2024-10-17 | Yes | $17.25 | 2000pcs | $34500.0 | 25.79% | $8897.56 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0FLXR8J8R | Dr. Scholl's | 2025-08-11 | Yes | $36.03 | 2000pcs | $72060.0 | 37.76% | $27209.86 |
![]() | B0FLY357SS | Dr. Scholl's | 2025-08-11 | Yes | $37.64 | 1000pcs | $37640.0 | 38.27% | $14404.83 |
![]() | B0FLY3KSFV | Dr. Scholl's | 2025-08-11 | Yes | $36.92 | 1000pcs | $36920.0 | 38.21% | $14107.14 |
![]() | B0FLY3V53V | Dr. Scholl's | 2025-08-11 | Yes | $36.03 | 1000pcs | $36030.0 | 38.08% | $13720.23 |
B0FLY3ZS3X | Dr. Scholl's | 2025-08-11 | Yes | $36.68 | 900pcs | $33012.0 | 36.39% | $12013.07 | |
![]() | B0FLY4HCJ9 | Dr. Scholl's | 2025-08-11 | Yes | $36.26 | 700pcs | $25382.0 | 37.95% | $9632.47 |
![]() | B0FLY5HH2S | Dr. Scholl's | 2025-08-11 | Yes | $36.29 | 400pcs | $14516.0 | 38.13% | $5534.96 |
![]() | B0FLY87GJZ | Dr. Scholl's | 2025-08-11 | Yes | $35.15 | 100pcs | $3515.0 | 33.69% | $1184.21 |
![]() | B0GYCSSPDM | OUOKK | 2026-04-24 | Yes | $26.45 | 100pcs | $2645.0 | 36.35% | $961.46 |
B0GRZHBR2P | OUOKK | 2026-03-10 | Yes | $26.45 | 100pcs | $2645.0 | 36.24% | $958.55 | |
![]() | B0G1RP8VKW | Psveb | 2026-02-01 | Yes | $23.85 | 100pcs | $2385.0 | 31.21% | $744.36 |
![]() | B0FLYFLTK8 | CRUVHEAL | 2025-08-11 | Yes | $19.99 | 50pcs | $999.5 | 27.18% | $271.67 |
![]() | B0GWZQ5LL8 | XGXC | 2026-06-30 | Yes | $14.07 | 100pcs | $1407.0 | 16.7% | $234.97 |
![]() | B0G2QSCL3P | ORHILYA | 2025-11-18 | Yes | $18.39 | 50pcs | $919.5 | 24.07% | $221.33 |
![]() | B0GJ5R8P2B | Gviipk | 2026-01-22 | Yes | $13.14 | 100pcs | $1314.0 | 13.63% | $179.1 |
![]() | B0GJ5MSTH3 | Gviipk | 2026-01-22 | Yes | $12.91 | 50pcs | $645.5 | 16.42% | $106.0 |
![]() | B0GJSHF5YW | XGXC | 2026-03-05 | Yes | $13.52 | 50pcs | $676.0 | 15.41% | $104.18 |
![]() | B0GJ8SS4DW | Gviipk | 2026-01-22 | Yes | $13.59 | 50pcs | $679.5 | 15.17% | $103.09 |
这个市场不适合进入,结论很直接:新品成功率只有16.98%,但失败率高达80%,而且近一年新品牌集中涌入已明显偏热;对于小商家来说,真正能站稳的只有少数低评论样本,整体不是可复制的低门槛机会。 预算上你有500000 CNY,足够覆盖单个新品的早期启动,但这个类目里想打赢,通常还要额外品牌投放和持续优化;如果没有足够品牌势能,按现在的数据进场大概率会被价格和流量挤压。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
What is the ratio of different brands owning all nonprofitable new products
结论很明确:这个市场不值得进入,已经处在明显的高竞争、低容错状态。 近一年新品成功率只有16.98%,而新品失败率高达80%~81.25%;最近一批批新品持续涌入,但利润结构并没有改善,反而大量落在10%以下甚至亏损,说明这里已经不是可轻松切入的市场,而是典型的高压价格战市场。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 0 | 2 | 8 | 0 | 22 |
| 2026 | 0 | 2 | 3 | 5 | 0 | 3 | 0 | 60 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/8 | 0 | 0 | 0 | 0 | 1 | 8 | 0 | 7 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 |
| 2025/10 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| 2025/11 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 7 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 1 | 3 | 3 | 0 | 0 | 0 | 14 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| 2026/3 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 4 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 4 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14 |
| 2026/6 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 4 |
| 2026/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18 |